TCM
ABMD

TimesSquare Capital Management’s Abiomed Inc ABMD Stock Holding History

TimesSquare Capital Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-19,900
Closed -$5.51M – 250
2020
Q3 		$5.51M Sell
19,900
-33,400
-63% -$9.62M 0.05% 206
2020
Q2 		$12.9M Buy
53,300
+3,300
+7% +$663K 0.12% 194
2020
Q1 		$7.26M Buy
+50,000
New +$8.3M 0.09% 199

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

TimesSquare Capital Management's ABMD Position: Q4 2020 in Review

TimesSquare Capital Management sold out of Abiomed Inc (ABMD) in Q4 2020, closing a stake of 19,900 shares — an estimated $5.51M sold.

TimesSquare Capital Management first reported a position in ABMD in Q1 2020 and held it in 3 quarters. The position peaked at $12.9M in Q2 2020. 498 funds tracked by Wall St. Rank hold ABMD as of Q4 2020.

  • TimesSquare Capital Management reported no remaining Abiomed Inc position as of Q4 2020 after selling out during the quarter.
  • TimesSquare Capital Management sold 19,900 Abiomed Inc shares in Q4 2020, an estimated $5.51M.
  • TimesSquare Capital Management first reported a position in Abiomed Inc in Q1 2020 and held it in 3 quarters.
  • TimesSquare Capital Management's Abiomed Inc position peaked at $12.9M in Q2 2020.
  • 498 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2020.

Based on TimesSquare Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.